We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-9.46%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.04B
AUM Growth
-$146M
Cap. Flow
+$10.4M
Cap. Flow %
1%
Top 10 Hldgs %
95.14%
Holding
20
New
3
Increased
Reduced
2
Closed
3

Top Sells

Rank Stock Value
1
ZS icon
Zscaler
ZS
+$54.1M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$9.83M
3
DNLI icon
Denali Therapeutics
DNLI
+$8.18M
4
CLDR
Cloudera, Inc.
CLDR
+$6.5M
5
XYZ
Block Inc
XYZ
+$1.81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.87%
2 Healthcare 18.52%
3 Technology 13.77%
4 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
1
JD.com
JD
$40.8B
$354M 33.87%
13,553,474
ARRS
2
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$252M 24.16%
9,703,500
DOCU
3
DocuSign
DOCU
$9.63B
$76.8M 7.36%
1,461,106
MNTV
4
DELISTED
Momentive Global Inc. Common Stock
MNTV
$73.9M 7.08%
+4,608,705
New +$75.9M
RCUS icon
5
Arcus Biosciences
RCUS
$3.57B
$70.4M 6.74%
5,049,786
ZS icon
6
Zscaler
ZS
$23B
$59.1M 5.66%
1,448,219
-1,340,341
-48% -$54.1M
DNTH icon
7
Dianthus Therapeutics
DNTH
$5.68B
$40.1M 3.84%
208,696
FTSV
8
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$23.1M 2.21%
1,545,966
SNAP icon
9
Snap
SNAP
$7.32B
$22.2M 2.13%
2,618,548
AUTL
10
Autolus Therapeutics
AUTL
$386M
$21.9M 2.1%
714,072
GRTS
11
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$13.2M 1.27%
+929,022
New +$13.2M
EVLO
12
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$12.9M 1.24%
53,025
SPRO icon
13
Spero Therapeutics
SPRO
$68.9M
$11.7M 1.12%
1,112,473
CLDR
14
DELISTED
Cloudera, Inc.
CLDR
$7.55M 0.72%
427,710
-427,710
-50% -$6.5M
PS
15
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$3.25M 0.31%
101,442
SPOT icon
16
Spotify
SPOT
$99.2B
$1.74M 0.17%
+9,646
New +$1.77M
DBX icon
17
Dropbox
DBX
$6.81B
$350K 0.03%
13,033
DNLI icon
18
Denali Therapeutics
DNLI
$3.67B
-536,411
Closed -$8.18M
XFOR icon
19
X4 Pharmaceuticals
XFOR
$363M
-2,508
Closed -$9.83M
XYZ
20
Block Inc
XYZ
$45.9B
-29,400
Closed -$1.81M

Similar funds

Alphabet Inc's Q3 2018 Portfolio in Review

As of Q3 2018, Alphabet Inc held 20 positions worth $1.04B, down 12% from $1.19B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Alphabet Inc's Q3 2018 filing shows 3 new, 2 reduced and 3 closed positions. Its largest new stake was Momentive Global Inc. Common Stock: 4,608,705 shares worth $73.9M. The largest sale was Zscaler, an estimated $54.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, down from 44% a quarter earlier, followed by Healthcare and Technology.

  • Alphabet Inc's largest Q3 2018 buy was Momentive Global Inc. Common Stock: 4,608,705 shares worth $73.9M.
  • Alphabet Inc's biggest Q3 2018 reduction was Zscaler, cutting an estimated $54.1M.
  • Alphabet Inc fully exited X4 Pharmaceuticals in Q3 2018, selling an estimated $9.83M.
  • Alphabet Inc's ten largest holdings make up 95% of its $1.04B portfolio in Q3 2018.
  • Alphabet Inc opened 3 new positions and closed 3 in Q3 2018.
  • Alphabet Inc's portfolio value fell 12% quarter-over-quarter to $1.04B.

Based on Alphabet Inc's 13F filing for Q3 2018, filed 15 Nov 2022.